4 ms·
The bar is pretty high for anybody who wants to make a product based on in-human CRISPR: https://www.broadinstitute.org/partnerships/office-strategic-alliances-
by dekhn 10y ago
The bar is pretty high for anybody who wants to make a product based on in-human CRISPR: https://www.broadinstitute.org/partnerships/office-strategic-alliances-and-partnering/information-about-licensing-crispr-genome-edi https://www.broadinstitute.org/partnerships/office-strategic...
In short, if you want to sell a product, Editas gets right of first refusal to license from Broad, and only if they refuse would the startup be able to proceed to license. If you just want to use CRISPR for in house research, you have to license it; no idea if the fees are prohibitive.